Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $57.75 USD
Change Today +0.15 / 0.26%
Volume 8.5M
MRK On Other Exchanges
Symbol
Exchange
EN Paris
Sao Paulo
Frankfurt
As of 8:04 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Willie A. Deese

Executive Vice President and President of Merck Manufacturing Division, Merck & Co. Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 2 different organizations across 3 different industries.

See Board Relationships
59--

Background*

Mr. Willie A. Deese has been an Executive Vice President of Merck & Co. Inc. since January 2008. Mr. Deese has been President of Merck Manufacturing Division at Merck & Co. Inc. since May 2005. He oversees 92 manufacturing sites spanning 30 countries, has led manufacturing for the introduction of multiple new medicines and vaccines, and implemented lean manufacturing across manufacturing network. He joined Merck in January 2004 as Senior Vice President of Global Procurement. ...

Read Full Background

Corporate Headquarters*

2000 Galloping Hill Road
Kenilworth, New Jersey 07033

United States

Phone: 908-740-4000
Fax: --

Board Members Memberships*

Director, Chairman of Compensation Committee and Member of Audit Committee
2011-Present
Director and Member of Audit & Finance Committee

Education*

MBA 1983
Western New England College
BA 1977
North Carolina A&T State University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:US $57.75 USD +0.15

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€3.2M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.4M
Serge Weinberg Chairman, Interim Chief Executive Officer, Chairman of Strategy Committee and Chairman of Appointments & Governance Committee
Sanofi
€700.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.